Avner Lushi
CIK: 0002033604
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Lushi Avner
Lushi Avner (SEC CIK 0002033604) files insider reports with the SEC as Director of Brainsway Ltd. (BWAY) and Director of Silexion Therapeutics Corp (SLXN).
Signal8 holds 3 ownership filings by Lushi Avner (1 Form 3, 2 Form 4), filed between Dec 31, 2025 and Mar 18, 2026. Those filings report 2 transactions, from Feb 9, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lushi Avner's filings is in RAMAT GAN, L3.
Recent filings by Lushi Avner
Other insiders filing for Brainsway Ltd. (BWAY)
- Moiseyev Gilad, Chief Technology Officer
- Roth Yiftach, Chief Scientist
- Mitrany Rayten Michal Ety, Director
- Zangen Abraham, Director
- Zacut David, Director
- Marom Ido, Chief Financial Officer